Protective effects of Ginkgo biloba against rat liver carcinogenesis

Chemico-Biological Interactions

Volumn 173, Issue 1, 2008, Pages 32-42

  Dias, Marcos C ^a   Rodrigues, Maria A M ^a   Reimberg, Maria C H ^b   Barbisan, Luís F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Grupo CentroFlora   (Brazil)

Author keywords

Chemoprevention; Diethylnitrosamine; Ginkgo biloba; GST P positive preneoplastic foci; Liver carcinogenesis; Putative initiated hepatocytes

Indexed keywords

CYCLINE; DIETHYLNITROSAMINE; GINKGO BILOBA EXTRACT; GLUTATHIONE S TRANSFERASE P; PROTEIN P53; TRANSFERASE; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; GINKGO BILOBA; IMMUNOREACTIVITY; LIVER CARCINOGENESIS; LIVER RESECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; BIOLOGICAL ASSAY; CARCINOGENS; DIETHYLNITROSAMINE; GINKGO BILOBA; GLUTATHIONE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PLANT EXTRACTS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; GINKGO BILOBA; RATTUS; RATTUS NORVEGICUS;

EID: 41949098914     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.01.012     Document Type: Article

References (45)

1. Jacobs B.P., and Browner W.S. Ginkgo biloba: a living fossil. Am. J. Med. 108 (2000) 341-342
2. Ahlemeyer B., and Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol. Life Sci. 60 (2003) 1779-1792
3. DeFeudis F.V., Papadopoulos V., and Drieu K. Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam. Clin. Pharmacol. 17 (2003) 405-417
4. Boonkaew T., and Camper N.D. Biological activities of Ginkgo extracts. Phytomedicine 12 (2004) 318-323
5. Zhang W.R., Hayashi T., and Kitagawa H. Protective effect of ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol. Res. 22 (2000) 517-521
6. Luo Y. Ginkgo biloba neuroprotection: therapeutic implications in Alzheimer's disease. J. Alzheimers Dis. 3 (2001) 401-407
7. 4 in rats. Liver Int. 25 (2005) 1224-1232
8. He S.X., Luo J.Y., and Wang Y.P. Effects of extract from Ginkgo biloba on carbon tetrachloride-induced liver injury in rats. World J. Gastroenterol. 12 (2006) 3924-3928
9. Sener G., Omurtag G.Z., and Sehirli O. Protective effects of Ginkgo biloba against acetaminophen-induced toxicity in mice. Mol. Cell Biochem. 283 (2006) 39-45
10. Naik S.R., and Panda V.S. Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents. Liver Int. 27 (2007) 393-399
11. Sasaki K., Hatta S., and Wada K. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sci. 70 (2002) 1657-1667
12. Ryu S.D., and Chung W.G. Induction of the procarcinogen-activating CYP1A2 by a herbal dietary supplement in rats and humans. Food Chem. Toxicol. 41 (2003) 861-866
13. Gaudineau C., Beckerman R., Welbourn S., and Auclair K. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem. Biophys. Res. Commun. 318 (2004) 1072-1078
14. Sugiyama T., Kubota Y., Shinozuka K., Yamada S., Yamada K., and Umegaki K. Induction and recovery of hepatic drug metabolizing enzymes in rats treated with Ginkgo biloba extract. Food Chem. Toxicol. 42 (2004) 953-957
15. Chao J.C., and Chu C.C. Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells. World J. Gastroenterol. 10 (2004) 37-41
16. Chen Q., Yang G.W., and An L.G. Apoptosis of hepatoma cells SMMC-7721 induced by Ginkgo biloba seed polysaccharide. World J. Gastroenterol. 8 (2002) 832-836
17. Ye B., Aponte M., Dai Y., Li L., Ho M.C., Vitonis A., Edwards D., Huang T.N., and Cramer D.W. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence. Cancer Lett. 251 (2007) 43-52
18. Kim K.S., Rhee K.H., Yoon J.H., Lee J.G., Lee J.H., and Yoo J.B. Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol. 41 (2005) 383-389
19. Agha A.M., El-Fattah A.A., Al-Zuhair H.H., and Al-Rikabi A.C. Chemopreventive effect of Ginkgo biloba extract against benzo(a)pyrene-induced forestomach carcinogenesis in mice: amelioration of doxorubicin cardiotoxicity. J. Exp. Clin. Cancer Res. 20 (2001) 39-50
20. Suzuki R., Kohno H., and Sugie S. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats. Cancer Lett. 210 (2004) 159-169
21. Bannasch P., and Zerban H. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response. In: Vainio H., Magee P., McGregor D., and McMichael A.J. (Eds). Mechanism of Carcinogenesis in Risk Identification, IARC Scientific Publication 116 (1992), International Agency of Research on Cancer, Lyon 389-427
22. Su Q., and Bannasch P. Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol. Pathol. 31 (2003) 126-133
23. Tatematsu M., Aoki T., Kagawa M., Mera Y., and Ito N. Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats. Carcinogenesis 9 (1988) 221-225
24. Moore M.A., Nakagawa K., Satoh K., Ishikawa T., and Sato K. Single GST-P positive liver cells-putative initiated hepatocytes. Carcinogenesis 8 (1987) 483-486
25. Satoh K., Hatayama I., and Tateoka N. Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis 10 (1989) 2107-2111
26. Moore M.A., Tsuda H., and Tamano S. Marriage of a medium-term liver model to surrogate markers: a practical approach for risk and benefit assessment. Toxicol. Pathol. 27 (1999) 237-242
27. Ito N., Tamano S., and Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci. 94 (2003) 3-8
28. Pinheiro F., Faria R.R., de Camargo J.L.V., Spinardi-Barbisan A.L., da Eira E.F., and Barbisan L.F. Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murrill in the rat. Food Chem. Toxicol. 41 (2003) 1543-1550
29. Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., Uwagawa S., Kagawa M., Ogiso T., and Masui T. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-an approach for a new medium-term bioassay system. Carcinogenesis 9 (1988) 387-394
30. Levin S., Bucci T.J., and Cohen S.M. The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists. Toxicol. Pathol. 27 (1999) 484-490
31. Verna L., Whysner J., and Williams G.M. N-Nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol. Ther. 71 (1996) 57-81
32. Swenberg J.A., Hoel D.G., and Magee P.N. Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine. Cancer Res. 51 (1991) 6409-6414
33. Nakae D., Kobayashi Y., Akai H., Andoh N., Satoh H., Ohashi K., Tsutsumi M., and Konishi Y. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res. 57 (1997) 1281-1287
34. Williams G.M., Iatropoulos M.J., and Wang C.X. Diethylnitrosamine exposure-responses for DNA damage, centrilobular cytotoxicity, cell proliferation and carcinogenesis in rat liver exhibits some non-linearities. Carcinogenesis 17 (1996) 2253-2258
35. Lennartsson P., Hogberg J., and Stenius U. Wild-type p53 expression in liver tissue and in enzyme-altered foci: an in vivo investigation on diethylnitrosamine-treated rats. Carcinogenesis 19 (1998) 1231-1237
36. Lennartsson P., Stenius U., and Hogberg J. P53 expression and TGF-alpha-induced replication of hepatocytes isolated from rats exposed to the carcinogen diethylnitrosamine. Cell Biol. Toxicol. 15 (1999) 31-39
37. Levine A.J. P53: the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
38. Dragan Y.P., Hully J.R., Nakamura J., Mass M.J., Swenberg J.A., and Pitot H.C. Biochemical events during initiation of rat hepatocarcinogenesis. Carcinogenesis 15 (1994) 1451-1458
39. Foley J., Ton T., Maronpot R., Butterworth B., and Goldsworthy T.L. Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. Environ. Health Perspect. 5 (1993) 199-205
40. Mead J.E., and Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 1558-1562
41. Gitano M., Wada J., Ariki Y., Kato M., Wanibuchi H., Morimura K., Hidaka T., Hosoe K., and Fukushima S. Possible tumour development from double positive foci for TGF-alpha and GST-P observed in early stages on rat hepatocarcinogenesis. Cancer Sci. 97 (2006) 478-483
42. Inoue Y., Tomiya T., and Yanase M. P53 may positively regulate hepatocyte proliferation in rats. Hepatology 36 (2002) 336-344
43. Satoh K., and Hatayama I. Anomalous elevation of glutathione S-transferase P-form (GST-P) in the elementary process of epigenetic initiation of chemical hepatocarcinogenesis in rats. Carcinogenesis 23 (2002) 1193-1198
44. Hwang E.S., and Kim G.H. Biomakers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology 229 (2007) 1-10
45. L.W. Wattenberg, Inhibition of tumorigenesis in animals, in: B.W. Stewart, D. McGregor, P. Kleihwes (Eds.), Principles of Chemoprevention, IARC Scientific Publication 139, International Agency of Research on Cancer, Lyon, 1996, pp. 151-158.